Toxicity of Cetuximab, Paclitaxel, Cisplatin and Concurrent Radiation in Chinese Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: An Open-label, Multicenter Phase II Study
机构：[1]Shandong Cancer Hospital, Jinan Shandong 250117, China[2]Cancer Hospital Affiliated to Zhengzhou University, Jinan Shandong 250117, China河南省肿瘤医院[3]Cancer Hospital, Chinese Academy of Medical Science, Peking Union Medical College, Beijing, China[4]Renji Hospital Affiliated to Shanghai Jiaotong University, Shanghai, China[5]Jiangsu Cancer Hospital, Nanjing, China[6]Beijing Cancer Hospital, School of Oncology, Peking University, Beijing, China[7]West China Hospital, West China School of Medicine, Sichuan University, Chengdu, China四川大学华西医院[8]Fourth Hospital, Hebei Medical University, Shijiazhuang, China河北医科大学第四医院胸部放疗三病区临床科室[9]The University of Texas MD Anderson Cancer Center, Houston, TX
第一作者机构：[1]Shandong Cancer Hospital, Jinan Shandong 250117, China
推荐引用方式(GB/T 7714)：
Yu J.,Wang J.,Sun X.,et al.Toxicity of Cetuximab, Paclitaxel, Cisplatin and Concurrent Radiation in Chinese Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: An Open-label, Multicenter Phase II Study[J].INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.2011,81(2):S315-S316.doi:10.1016/j.ijrobp.2011.06.512.
APA：
Yu, J.,Wang, J.,Sun, X.,Wang, L.,Ye, M....&Liao, Z..(2011).Toxicity of Cetuximab, Paclitaxel, Cisplatin and Concurrent Radiation in Chinese Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: An Open-label, Multicenter Phase II Study.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,81,(2)
MLA：
Yu, J.,et al."Toxicity of Cetuximab, Paclitaxel, Cisplatin and Concurrent Radiation in Chinese Patients with Locally Advanced Esophageal Squamous Cell Carcinoma: An Open-label, Multicenter Phase II Study".INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 81..2(2011):S315-S316
医学